Amelioration of collagen-induced arthritis by thrombin inhibition

Journal of Clinical Investigation

Volumn 107, Issue 5, 2001, Pages 631-640

  Marty, Ingrid ^a   Péclat, Veronique ^a   Kirdaite, Gailute ^a   Salvi, Roberto ^a   So, Alexander ^a   Busso, Nathalie ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COLLAGEN TYPE 2; FIBRIN; HIRUDIN; INTERLEUKIN 12; INTERLEUKIN 1BETA; MACROGOL; PROTEINASE ACTIVATED RECEPTOR 1; THROMBIN INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICOAGULATION; ARTHRITIS; ARTICLE; BLOOD CLOTTING TIME; CONTROLLED STUDY; DOWN REGULATION; FIBRIN DEPOSITION; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCORING SYSTEM; SYNOVIUM;

EID: 0035097191     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI11064     Document Type: Article

References (41)

1. Etiology and pathogenesis of rheumatoid arthritis
2. Rheumatoid arthritis
3. Cell biology of tissue factor, the principal initiator of blood coagulation
4. Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritis
5. Pathways of coagulation activation in situ in rheumatoid synovial tissue
6. Elastase and plasmin-mediated fibrinolysis in rheumatoid arthritis
7. Characteristics of the protease activity in synovial fluid from patients with rheumatoid arthritis and osteoarthritis
8. Fibrin and fibronectin in rheumatoid synovial membrane and rheumatoid synovial fluid
9. Fibrin: Metabolism immunopathogenesis and significance in rheumatoid arthritis
10. Thrombin functions as an inflammatory mediator through activation of its receptor
11. Regulation of extravascular coagulation by microvascular permeability
12. Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibinopeptide
13. Fibrin enhances the expression of IL-1 beta by human peripheral blood mononuclear cells. Implications in pulmonary inflammation
14. Fibrin degradation product D-dimer induces the synthesis and release of biologically active IL-1 beta, IL-6 and plasminogen activator inhibitors from monocytes in vitro
15. Fibrin activation of vascular endothelial cells. Induction of lL-8 expression
16. Exacerbation of antigen-induced arthritis in urokinase-deficient mice
17. Thrombin receptor-mediated synovial proliferation in patients with rheumatoid arthritis
18. Thrombin in the synovial fluid of patients with rheumatoid arthritis mediates proliferation of synovial fibroblast-like cells by induction of platelet derived growth factor
19. Thrombin in inflammation and healing: Relevance to rheumatoid arthritis
20. Sol Sherry lecture in thrombosis: How thrombin talks to cells: Molecular mechanisms and roles in vivo
21. Thrombin receptor expression in rheumatoid and osteoarthritic synovial tissue
22. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation
23. The development of hirudin as an antithrombotic drug
24. Pharmacokinetics and anticoagulant effect of hirudin in man
25. Antithrombotic efficacy of the polyethylenglycol-coupled hirudin mutein LU 57291 in experimentally induced venous and arterial thrombosis
26. Comparative pharmacodynamics of recombinant hirudin and its PEG-coupled derivatives in primates
27. Immunisation against heterologous type II collagen induces arthritis in mice
28. Type II collagen-induced arthritis in mice II. Passive transfer and suppression by intravenous injection of anti-type II collagen antibody or free native type II collagen
29. Effect of thrombin inhibition on synovial inflammation in antigen-induced arthritis
30. Enhanced expression of genes involved in coagulation and fibrinolysis in murine arthritis
31. Thrombin induces proteinase-activated receptor-gene expression in endothelial cells via activation of Gi-linked Ras mitogen-activated protein kinase pathway
32. Constitutive expression and modulation of the functional thrombin receptor in the human kidney
33. Control mechanisms in thrombin generation
34. High and constant plasma levels of tissue plasminogen activator and PEG-hirudin can be achieved by subcutaneous delivery
35. Stability of hirudin, a thrombin-specific inhibitor. The structure of alkaline-inactivated hirudin
36. Association of the course of collagen-induced arthritis with distinct patterns of cytokine and chemokine messenger RNA expression
37. Monocyte chemotaxis: Stimulation by specific exosite region in thrombin
38. Design and characterization of hirulogs: A novel class of bivalent peptide inhibitors of thrombin
39. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells
40. Thrombin-dependent, cell-mediated renal inflammation in crescentic glomeulonphritis
41. Antithrombin agents as anticoagulants and antithrombotics: Implications in drug development